Published in
10.02 - Tuberculosis and non-tuberculous mycobacterial diseases, 2022
DOI: 10.1183/13993003.congress-2022.3641
Links
Tools
Prevalence of sub-optimal drug levels of Rifampicin, Isoniazid and Pyrazinamide among tuberculosis patients in Sydney, Australia. A pilot study.
Proceedings article published in 2022 by
A. Byrne,
R. Wong,
D. Marriott,
D. Kocic,
J. Alffenaar,
J. G. Cho 
,
B. Marais
,
B. Marais
